Manufacturing & Quality

Featured on-site view: GuangLong manufacturing and R&D facility

Built for
Project Review

B2B project coordination supported by entity-level quality documentation, reviewed for each relevant project.

Project roles

Clear roles for a qualified project

Innovision Bio coordinates the B2B discussion. Documents, facility context and permissions remain attributed to the entity named in each record.

Innovision Bio

B2B commercial and project coordination, including scope alignment, target-market discussion and the controlled path for project materials.

GuangLong

Manufacturing and R&D facility context. Any facility qualification or production-related statement is limited to the document holder and stated scope.

Chuangxinli

A separately registered commercial entity. Its medical-device business licence is described only as an operating document and is not a product registration or manufacturing authorisation.

Entity-Level Qualifications

These reviewed documents are held by separately registered Chinese entities supporting Innovision Bio projects. Holder, stated scope, validity and project relevance are assessed individually.

ISO 9001

Holder: Qufu Guanglong Bioproduct Factory. ISO 9001:2015 certificate shown valid from 12 Feb 2024 to 11 Feb 2027; its documented scope is reviewed for the relevant project.

Affiliated manufacturing entity

Medical Device Business License

Holder: Qufu Chuangxinli Biotechnology Co., Ltd. Class III medical-device business licence shown valid from 9 Jan 2025 to 8 Jan 2030. It is a business-operation licence, not a manufacturing authorisation or product registration.

Affiliated trading entity

Cosmetics Production License

Holder: Qufu Guanglong Bioproduct Factory. Cosmetics production licence shown valid until 15 Nov 2026. Its documented scope does not approve an individual product or claim.

Affiliated manufacturing entity

These are entity-level documents, not product registrations, approvals or clinical evidence. Watermarked copies may be released only through the controlled-document process after holder authorisation and current-validity review.

Discuss Project Context

Share your target market and project scope so the relevant entity, documentation pathway and next discussion can be reviewed.

Start a B2B Discussion